Drip or shot? study tests best way to brighten heart scans

NCT ID NCT06400004

Recruiting now Diagnosis Sponsor: Bracco Diagnostics, Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two methods of giving a contrast agent called Lumason during heart ultrasound. It compares giving the drug as a slow drip versus a single injection to see which provides clearer images of the heart's left ventricle. The study involves 106 adults whose initial ultrasound images were not clear enough. The goal is to improve image quality for better diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART DISEASES

Contacts and locations

Locations

Beth Israel Deaconess Medical Center
RECRUITING

Boston, Massachusetts, 02215, United States
Interventional Cardiology Medical Group
RECRUITING

West Hills, California, 91307, United States
Oregon Health and Sciences University
NOT_YET_RECRUITING

Portland, Oregon, 97239, United States
Piedmont Heart Institute
RECRUITING

Atlanta, Georgia, 30309, United States
University of Texas Medical Branch
WITHDRAWN

Galveston, Texas, 77555, United States
Vital Heart and Vein
RECRUITING

Humble, Texas, 77338, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.